DR. RASHID ALI BUTTAR, D.O.
Medical Practice at Julian Clark Ave, Huntersville, NC

License number
North Carolina 95-00528
Category
Medical Practice
Type
Medical Toxicology
Address
Address
9630 Julian Clark Ave, Huntersville, NC 28078
Phone
(704) 895-9355
(704) 895-9357 (Fax)

Organization information

See more information about RASHID ALI BUTTAR at bizstanding.com

Rashid Ali Buttar

14316 Beatties Frd Rd, Huntersville, NC 28078

Status:
Inactive
Industry:
Business Services at Non-Commercial Site
Principal:
Rashid Buttar Principal, inactive

Professional information

Rashid A Buttar Photo 1

Dr. Rashid A Buttar, Cornelius NC - DO (Doctor of Osteopathic Medicine)

Specialties:
Emergency Medicine
Address:
Center For Advanced Medicine
19620 W Catawba Ave STE 100, Cornelius 28031
(704) 895-9355 (Phone)
9630 Julian Clark Ave, Huntersville 28078
(704) 895-9355 (Phone)
Languages:
English, Spanish
Hospitals:
Center For Advanced Medicine
19620 W Catawba Ave STE 100, Cornelius 28031
9630 Julian Clark Ave, Huntersville 28078
Novant Health Presbyterian Medical Center
10030 Gilead Rd, Huntersville 28078
Education:
Medical School
Des Moines University College Of Osteopathic Medicine
Graduated: 1991
Background:
Sanction:  1 time(s)


Rashid Ali Buttar Photo 2

Rashid Ali Buttar, Cornelius NC

Specialties:
Toxicologist
Address:
19620 W Catawba Ave, Cornelius, NC 28031
9630 Julian Clark Ave, Huntersville, NC 28078


Rashid Buttar Photo 3

Transdermal Delivery Systems And Transdermal Chelation Preparations

US Patent:
2008026, Oct 23, 2008
Filed:
May 6, 2005
Appl. No.:
11/568768
Inventors:
Rashid A. Buttar - Huntersville NC, US
Dean Charles Viktora - Charlotte NC, US
International Classification:
A61K 9/12, A61K 38/02, A61K 31/00
US Classification:
424 45, 514 2, 424 941
Abstract:
The invention provides topical chelating preparations and formulations. The invention provides methods of transepithelial delivery of a topical chelating preparation to a human or other animal by topical application to the skin of a human or animal of a topical chelating preparation. In one aspect, a preparation or formulation of the invention comprises a combination comprising of 2-3, dimercaptopropane-1-sulfonate (DMPS) or glutathione, and methionine, in a stabilizing base.